The administration shows no coherent commitment to free market principles and is in fact actively undermining them.

SEOUL, May 15 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

French pharmaceutical firm Sanofi said Wednesday it plans to invest at least $20 billion into its operations in the United ...

Ro Khanna announced plans to introduce legislation to codify the president's directive aimed at lowering prescription drug ...

Gov. Gavin Newsom announced that he will seek to regulate prescription drug managers that he blames for driving up costs for ...

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in ...

President Trump has elevated an issue Democrats have been jawboning about for years. On Monday the president issued an ...

We can have a world where everyone has access to the medicines they need. But both Trump and pharma companies will push us in ...

Trump’s EO on MFN prescription drugs to strengthen adoption of generics & biosimilars: Nandita Vijayasimha, Bengaluru Thursday, May 15, 2025, 08:00 Hrs [IST] US President Donald ...